Literature DB >> 33694097

SUPPORT-AF III: supporting use of AC through provider prompting about oral anticoagulation therapy for AF.

Hammad Sadiq1, Laboni Hoque1, Qiming Shi1, Gordon Manning1,2, Sybil Crawford1, David McManus1,2, Alok Kapoor3,4,5.   

Abstract

Only half of atrial fibrillation (AF) patients with elevated stroke risk receive anticoagulation (AC). Electronic health record (EHR) alerts have the potential to close the gap. We designed an outpatient EHR alert (linked to an order set for ordering AC, labs, and specialty referrals) that fired when cardiology and primary care providers (PCPs) saw AF patients not on AC. We assigned all untreated patients seen by cardiology providers and PCPs in the 8 months before and after the alert launch to pre- and post-launch intervention cohorts, respectively. Untreated AF patients seeing other types of providers became controls. We then compared the difference in AC starts between intervention and control patients post-launch to the same difference prelaunch (adjusting for covariates). We measured alert responsiveness as how often patients had at least one encounter with a provider, who interacted with the alert. The adjusted percentage of AC starts for the prelaunch cohort was 20% for intervention patients and 17% for controls (difference = 3%); post-launch, the percentage was 13% for both post-launch intervention and controls (difference = 0%). The difference in difference was - 3% (p value 0.63). For half of patients, at least one provider was responsive to our alert. Reasons for no AC commonly included relative contraindications (e.g. fall, gastrointestinal bleed). Our alert did not increase AC starts but responsiveness to it was high. Increasing AC starts will likely require education surrounding relative contraindications.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Anticoagulation; Atrial fibrillation; Clinical studies; Electronic medical record; Practice management; Quality and outcomes

Mesh:

Substances:

Year:  2021        PMID: 33694097     DOI: 10.1007/s11239-021-02420-8

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  10 in total

1.  Alert-based computerized decision support for high-risk hospitalized patients with atrial fibrillation not prescribed anticoagulation: a randomized, controlled trial (AF-ALERT).

Authors:  Gregory Piazza; Shelley Hurwitz; Claire E Galvin; Lindsay Harrigan; Sofia Baklla; Benjamin Hohlfelder; Brett Carroll; Adam B Landman; Srinivas Emani; Samuel Z Goldhaber
Journal:  Eur Heart J       Date:  2020-03-07       Impact factor: 29.983

2.  Massachusetts Health Reform Cost Less and Was More Effective for Uninsured Individuals With Venous Thromboembolism: A Cost-Effectiveness Analysis.

Authors:  Alok Kapoor; Nicholas Shaffer; Amresh Hanchate; Mark Roberts; Kenneth Smith
Journal:  Med Care       Date:  2016-05       Impact factor: 2.983

Review 3.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

4.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Authors:  Paulus Kirchhof; Stefano Benussi; Dipak Kotecha; Anders Ahlsson; Dan Atar; Barbara Casadei; Manuel Castella; Hans-Christoph Diener; Hein Heidbuchel; Jeroen Hendriks; Gerhard Hindricks; Antonis S Manolis; Jonas Oldgren; Bogdan Alexandru Popescu; Ulrich Schotten; Bart Van Putte; Panagiotis Vardas
Journal:  Eur Heart J       Date:  2016-08-27       Impact factor: 29.983

5.  Automated Software System to Promote Anticoagulation and Reduce Stroke Risk: Cluster-Randomized Controlled Trial.

Authors:  Tim A Holt; Andrew Dalton; Tom Marshall; Matthew Fay; Nadeem Qureshi; Susan Kirkpatrick; Jenny Hislop; Daniel Lasserson; Karen Kearley; Jill Mollison; Ly-Mee Yu; F D Richard Hobbs; David Fitzmaurice
Journal:  Stroke       Date:  2017-01-24       Impact factor: 7.914

6.  SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation: A Cluster-Randomized Study of Electronic Profiling and Messaging Combined With Academic Detailing for Providers Making Decisions About Anticoagulation in Patients With Atrial Fibrillation.

Authors:  Alok Kapoor; Azraa Amroze; Fatima Vakil; Sybil Crawford; Jacqueline Der; Jomol Mathew; Eric Alper; Dinesh Yogaratnam; Saud Javed; Rasha Elhag; Abraham Lin; Siddhartha Narayanan; Donna Bartlett; Ahmed Nagy; Bevin Kathleen Shagoury; Michael A Fischer; Kathleen M Mazor; Jane S Saczynski; Jeffrey M Ashburner; Renato Lopes; David D McManus
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-02-17

7.  Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

Authors:  Gregory Y H Lip; Robby Nieuwlaat; Ron Pisters; Deirdre A Lane; Harry J G M Crijns
Journal:  Chest       Date:  2009-09-17       Impact factor: 9.410

8.  Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.

Authors:  Michael W Cullen; Sunghee Kim; Jonathan P Piccini; Jack E Ansell; Greg C Fonarow; Elaine M Hylek; Daniel E Singer; Kenneth W Mahaffey; Peter R Kowey; Laine Thomas; Alan S Go; Renato D Lopes; Paul Chang; Eric D Peterson; Bernard J Gersh
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-06-11

9.  A clinical decision support tool for improving adherence to guidelines on anticoagulant therapy in patients with atrial fibrillation at risk of stroke: A cluster-randomized trial in a Swedish primary care setting (the CDS-AF study).

Authors:  Lars O Karlsson; Staffan Nilsson; Magnus Bång; Lennart Nilsson; Emmanouil Charitakis; Magnus Janzon
Journal:  PLoS Med       Date:  2018-03-13       Impact factor: 11.069

10.  SUPPORT-AF: Piloting a Multi-Faceted, Electronic Medical Record-Based Intervention to Improve Prescription of Anticoagulation.

Authors:  Alok Kapoor; Azraa Amroze; Jessica Golden; Sybil Crawford; Kevin O'Day; Rasha Elhag; Ahmed Nagy; Steve A Lubitz; Jane S Saczynski; Jomol Mathew; David D McManus
Journal:  J Am Heart Assoc       Date:  2018-09-04       Impact factor: 5.501

  10 in total
  1 in total

1.  SUPPORT-AF IV: Supporting use of AC through provider prompting about oral anticoagulation therapy for AF clinical trial study protocol.

Authors:  Jay Patel; Hammad Sadiq; John Catanzaro; Sybil Crawford; Adam Wright; Gordon Manning; Jeroan Allison; Kathleen Mazor; David McManus; Alok Kapoor
Journal:  Cardiovasc Digit Health J       Date:  2021-07-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.